相关实验视频
Updated: Jun 3, 2025

08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
10.8K
人体血清白蛋白的糖尿病糖化会影响其免疫性
Cresci-Anne C C Croes1, Marialena Chrysanthou2,3, Tamara Hoppenbrouwers2,4
1Department of Cell Biology and Immunology, Wageningen University and Research Centre, 6700 AH Wageningen, The Netherlands.
Biomolecules
|January 8, 2025
概括
在人血清白蛋白 (HSA) 上,先进的糖化最终产品 (AGE) 修改的类型会影响其免疫效应. 甲基醇 (MGO) 修饰的HSA显示出最强的炎症反应,影响与糖尿病相关的免疫失调.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 先进的糖化最终产品 (AGEs) 由糖和蛋白质之间的非酶反应形成.
- 糖化人血清白蛋白 (HSA) 在糖尿病中增加,这是由于高血糖和甲基甘 (MGO) 等代谢物.
- 不同类型的AGE对HSA的免疫调节作用尚不清楚.
研究的目的:
- 调查不同的糖化方法 (D-葡萄糖,MGO,糖酸/CML) 如何影响HSA的结构和免疫调节特性.
- 为了确定糖化HSA与AGE受体的结合亲和力.
- 评估糖化HSA对免疫细胞中炎症标志物的影响.
主要方法:
- 使用D-葡萄糖,MGO和葡萄糖酸进行了HSA的糖化.
- 生物化学方法的特征是糖化诱导的变化.
- 抑制ELISA测量了与AGE受体的结合.
- 使用THP-1巨细胞和人体外围血液单核细胞 (PBMC) 衍生的单细胞来研究炎症反应.
主要成果:
- 所有的糖化方法都改变了HSA结构,并增加了它与AGE受体的结合,MGO-HSA显示了最高的结合.
- 在THP-1巨细胞中,MGO-HSA诱导了显著的促炎标记表达和NF-κB p65酸化.
- 葡萄糖-HSA和CML-HSA也增加了炎症标志物,CML-HSA在PBMC单细胞中引起了更强烈的反应.
结论:
- 特定类型的糖化显著影响HSA与AGE受体的相互作用及其促炎潜力.
- 由MGO诱导的HSA糖化显示出强烈的炎症作用,与糖尿病并发症相关.
- 这些发现突显了各种AGE在糖尿病中的不同免疫调节作用.
关键词:
年龄的 AGEs.在HSA中,HSA就是HSA.愤怒的愤怒 愤怒的愤怒糖尿病 糖尿病患者 糖尿病患者这是一种炎症炎症炎症炎症.巨细胞是什么?巨细胞是什么?甲基格里奥克萨尔 (Methylglyoxal) 是一种这些受体是受体受体.更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142
Insulin: Biosynthesis, Chemistry, and Preparation
354
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
354
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150

